AGEX THERAPEUTICS, INC. 8-K

Company

Serina Therapeutics, Inc.

Filed

November 29, 2018

Period of Report

November 29, 2018

Accession Number

0001157523-18-002491

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →